The Efficacy of Intranasal Insulin in the Treatment of Post-Viral Persistent Olfactory Dysfunction: A Systematic Review
Clinical and Experimental Otorhinolaryngology · 31.05.2026 · 19 (2) · 120-128
DOI: 10.21053/ceo.2025-00252 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Experimental Otorhinolaryngology, erschienen am 31.05.2026. Verfasst von Do Hyun Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korean Fund for Regenerative Medicine.
Abstract (Originalsprache)
Objectives
This study aimed to evaluate the therapeutic efficacy of intranasal insulin in treating persistent and refractory olfactory dysfunction following viral infections.
Methods
A comprehensive literature search was performed across PubMed, Scopus, Embase, Web of Science, Google Scholar, and the Cochrane Library, covering all articles indexed up to July 2025. Studies were included if they evaluated changes in olfactory scores in patients receiving intranasal insulin, either compared with a control group (placebo or no treatment) or between pre- and post-treatment measurements. Secondary outcomes included serum glucose and insulin levels and the proportion of patients achieving significant olfactory recovery.
Results
Eight studies including 457 participants were reviewed. Intranasal insulin was generally associated with improvement in olfactory scores. Delivery via absorbable materials may enhance both threshold and discrimination outcomes, whereas self-administration demonstrated minimal benefit. Several studies also reported higher rates of substantial olfactory recovery with absorbable material-based delivery. Combination therapy with intranasal insulin and budesonide was suggested to further improve threshold scores. Overall, treatment was well tolerated, with no major changes in serum glucose levels, although one study documented a mild hypoglycemic event.
Conclusion
Current evidence suggests that intranasal insulin, particularly when delivered using absorbable materials, may offer therapeutic benefit for persistent post-viral olfactory dysfunction. Corticosteroid coadministration may also provide additional improvements. These findings remain preliminary and require confirmation in larger, well-controlled studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Department of Head and Neck Surgery and Communication Sciences, Duke University School of Medicine, Durham, NC, USA.
- Department of Otolaryngology-Head and Neck Surgery, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea. yellobird@catholic.ac.kr.
Förderung
- Korean Fund for Regenerative Medicine
Zitieren
APA
Kim, D. H., Jang, D. W., & Hwang, S. H. (2026). The Efficacy of Intranasal Insulin in the Treatment of Post-Viral Persistent Olfactory Dysfunction: A Systematic Review. Clinical and Experimental Otorhinolaryngology, 19(2), 120-128. https://doi.org/10.21053/ceo.2025-00252
Vancouver
Kim DH, Jang DW, Hwang SH. The Efficacy of Intranasal Insulin in the Treatment of Post-Viral Persistent Olfactory Dysfunction: A Systematic Review. Clinical and Experimental Otorhinolaryngology. 2026;19(2):120-128. doi:10.21053/ceo.2025-00252
BibTeX
@article{Kim2026,
author = {Kim, Do Hyun and Jang, David W and Hwang, Se Hwan},
title = {The Efficacy of Intranasal Insulin in the Treatment of Post-Viral Persistent Olfactory Dysfunction: A Systematic Review},
journal = {Clinical and Experimental Otorhinolaryngology},
year = {2026},
volume = {19},
number = {2},
pages = {120--128},
doi = {10.21053/ceo.2025-00252}
}
EUVIMED